Establishing a reference interval for serum anti-dsDNA antibody: A large Chinese Han population-based multi-center

Chuiwen Deng1,2, Shulan Zhang1,2, Chaojun Hu1,2

  • 1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Plos One
|February 3, 2017
PubMed

Insights

This study established gender-specific reference intervals for anti-double-stranded DNA (dsDNA) antibody concentrations in the Chinese Han population. These findings are crucial for accurate clinical interpretation and decision-making.

Area of Science:

  • Clinical immunology
  • Laboratory medicine
  • Population health studies

Background:

  • Accurate reference intervals (RIs) for anti-dsDNA antibody are vital for clinical decision-making.
  • Establishing population-specific RIs ensures reliable laboratory result interpretation.
  • The Chinese Han population lacked established RIs for anti-dsDNA antibody.

Purpose of the Study:

  • To establish reference intervals (RIs) for serum anti-double-stranded DNA (dsDNA) antibody.
  • To define gender-specific RIs for the Chinese Han population.
  • To provide essential data for clinical laboratories in China.

Main Methods:

  • Study conducted following CLSI guideline C28-A3.
  • 2,880 healthy individuals recruited from four Chinese regions.
  • Serum anti-dsDNA antibody measured using AESKU, EUROIMMUNE, and INOVA systems.
  • Nonparametric methods used to determine RIs after stratification by gender, age, and region.

Main Results:

  • Gender-specific reference intervals (RIs) for serum anti-dsDNA antibody were successfully established.
  • RIs were determined for the Chinese Han population across different regions.
  • Data generated for commonly used analytical systems in China.

Conclusions:

  • This study presents the first reference intervals for anti-dsDNA antibody in the Chinese Han population.
  • Established gender-specific RIs are available for major assay methods used in China.
  • These RIs will aid in the accurate diagnosis and management of autoimmune diseases.
Abstract

Related Concept Videos